Related Experiment Video
Updated: May 2, 2026

08:07
Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
Published on: September 6, 2017
10.1K
Two-field resolution on-call HLA typing for deceased donors using nanopore sequencing
Magali Devriese1,2, Sephora Da Silva1, Melchior Le Mene1
1Laboratoire d'Immunologie et Histocompatibilité, Hôpital Saint Louis, Paris, France.
HLA
|March 20, 2024
Summary
Rapid HLA typing for deceased donors using nanopore sequencing significantly improves organ allocation accuracy. This method provides high-resolution genotyping within critical timeframes, benefiting highly sensitized recipients.
Area of Science:
- Immunogenetics
- Transplantation immunology
- Molecular diagnostics
Background:
- Current HLA genotyping methods for deceased donors face time and resolution limitations.
- Accurate HLA compatibility assessment is crucial for anti-HLA sensitized recipients, especially with allele-specific antibodies.
- Timely and precise HLA data is essential for organ allocation decisions.
Purpose of the Study:
- To develop and validate a rapid, high-resolution HLA genotyping protocol for deceased donors.
- To assess the feasibility of using nanopore sequencing for real-time HLA typing in deceased organ donation.
- To improve organ allocation security for highly sensitized recipients.
Main Methods:
- A customized protocol using the NanoTYPE® HLA typing kit and MinION® sequencer was developed.
- Prospective real-time analysis of HLA typing was performed on 18 deceased donors.
- The nanopore-based method's speed and accuracy were compared to conventional approaches.
Main Results:
- The protocol achieved average HLA typing in 3.75 hours with three-field resolution and minimal ambiguity.
- The method's duration was compatible with organ donation and allocation timelines.
- The enhanced resolution improved the security of organ allocation, particularly for complex cases.
Conclusions:
- Nanopore-based HLA typing offers a rapid and accurate solution for deceased donors.
- This approach enhances organ allocation safety and efficiency, especially for vulnerable recipients.
- The protocol has the potential to significantly impact deceased donor HLA genotyping practices.

